Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 3Waldenstrom Macroglobulinemia 1Stomatitis 1Lung Neoplasms 1Leukemia 1Head and Neck Neoplasms 1Glioblastoma 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 59Cisplatin 45Cetuximab 29Radiotherapy 26Carboplatin 24Docetaxel 17Paclitaxel 16Nivolumab 16Surveys and Questionnaires 15Radiotherapy, Intensity-Modulated 13Fluorouracil 12Drug Therapy 12Blood Specimen Collection 11Standard of Care 8tislelizumab 7cemiplimab 6atezolizumab 6Radiation 6Chemoradiotherapy 6toripalimab 5Cyclophosphamide 5130-nm albumin-bound paclitaxel 5nimotuzumab 4fludarabine 4durvalumab 4dostarlimab 4Surgical Procedures, Operative 4Afatinib 4palbociclib 3niraparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Valacyclovir × 1 year × Clear all
NCT07363031 2026-01-23

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

Instituto Oncoclinicas

Phase 2 Enrolling by invitation
84 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡